Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Companhia Brasileira de Distribuição

CBDNYSE
Consumer Cyclical
Department Stores
$0.45
$-0.01(-3.05%)
U.S. Market opens in 16h 0m

Companhia Brasileira de Distribuição (CBD) Stock Competitors & Peer Comparison

See (CBD) competitors and their performances in Stock Market.

Peer Comparison Table: Department Stores Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CBD$0.45-3.05%218.1M-14.83-$0.03N/A
DDS$582.66+1.55%9.1B16.01$36.43+5.36%
M$17.05-0.70%4.5B10.02$1.70+4.35%
JWN$24.66+0.08%4.1B14.17$1.74N/A
PLBL$9.01-0.44%3.2B-293.33-$0.03N/A
KSS$13.18-0.68%1.5B7.61$1.73+3.79%
EXTO$3.61-0.55%585.7M90.25$0.04N/A
DDT$26.00+0.12%411MN/AN/A+7.21%

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CBD vs DDS Comparison March 2026

CBD plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CBD stands at 218.1M. In comparison, DDS has a market cap of 9.1B. Regarding current trading prices, CBD is priced at $0.45, while DDS trades at $582.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CBD currently has a P/E ratio of -14.83, whereas DDS's P/E ratio is 16.01. In terms of profitability, CBD's ROE is -0.59%, compared to DDS's ROE of +0.30%. Regarding short-term risk, CBD is more volatile compared to DDS. This indicates potentially higher risk in terms of short-term price fluctuations for CBD.Check DDS's competition here

Stock price comparison of stocks in the Consumer Cyclical Sector

Loading...

Frequently Asked Questions